Startups

MBD

MBD (Medical & Bio Decision) is a South Korean biotechnology company that builds three-dimensional cell-culture and tumor-organoid platforms for precision oncology and drug development. It uses patient-derived cancer cells to assess anticancer drug sensitivity and offers the OncoSensi testing service to help evaluate treatment response. Its Cellvitro, ASFA Spotter and ASFA Scanner products support automated cell culture and drug screening, while its CRO services evaluate drug efficacy and toxicity for pharmaceutical and research partners.

Founded 2015

Team

Bo Sung KuCEO

Cheol Soo ChoiScientific Advisory Committee Member

Don Jung LeeDirector & Head of Management Support

Dong Woo LeeScientific Advisory Committee Chair

Gyuha RyuScientific Advisory Committee Member

Hee Chul KimDirector & Head of Bio 3

Jae Gyun LimCCO, Executive Vice President & Head of Clinical Research

Jeong Won LeeScientific Advisory Committee Member

Jin-Ku LeeScientific Advisory Committee Member

Jonathan S. DordickScientific Advisory Committee Member

Kwang Hak ChoiDirector & Head of Strategic Planning

Sang Hyun LeeManaging Director & Head of Bio 1

Sang Youl JeonManaging Director & Head of Medical Devices

Seung Joon KimScientific Advisory Committee Member

Yongmun ChoiDirector & Head of Bio 2

Investments

₩16.5BUnknown date	0 participations
$—Unknown date	Samsung Venture Investment Corporation